The isotonic solution in the syringe ready for injection Viscor contains hyaluronic acid, sodium chloride, monobasic sodium phosphate, dibasic sodium phosphate and injectable water.

Viscor is used to reduce pain and movement limitations in the joints caused by cartilage depletion as well as injuries caused by synovial fluid changes in large joints, including the knees and shoulders.

Intravenous injection of Viscor is absolutely contraindicated because it may cause systemic adverse effects.
Viscor is contraindicated in patients with the following conditions:
Patients with a history of allergies to sodium hyaluronate or its derivatives
- Patients with infections or skin diseases at the injection site
- Patients whose joint fluid is highly inflamed or infected
- Patients with systemic bleeding disorders

If the syringe is damaged or the blister is open, do not inject it separately.
If the product is stored in the refrigerator, bring the product to room temperature before injection.
Viscor is designed for single dose and single injection only; if the product is used twice, there is no guarantee that the drug will remain functional and sterile, and it may lead to injury and infection of the patient's joint.
Do not inject after the expiration date on the box or the Viscor syringe label.
Do not inject after the expiration date on the box or the Viscor syringe label.
Keep out of reach of children.

In rare cases, whiskey injections may cause allergies, and in very rare cases, they may cause anaphylactic shock.
See your doctor or nurse immediately if you have any of the following symptoms:
- Skin lesions, itching
Swelling of the face, lips or tongue
Cough, shortness of breath
These side effects may occur both during and after the injection.
Symptoms such as pain, swelling, temporary inflammation, a feeling of warmth or redness in the treated joint may occur after intra-articular injection of Viscor. These symptoms are temporary and can be relieved by joint rest or cooling with ice packs. See your doctor if you do not have relief from any of these symptoms for up to 4 days or if you experience any of these symptoms.
People with autoimmune or connective tissue disorders are more likely to have side effects.

Children: Use the drug with caution as the safety of the drug in children has not been evaluated.
Pregnant women: Viscor's safety during pregnancy has not been proven and should be used with caution.
Breastfeeding women: Although the side effects of breastfeeding have not been proven, it is recommended to be used with caution during this period.

Viscor ready-to-inject syringes should only be injected once or twice by an experienced physician. Depending on the severity of the disease, several joints can be treated at the same time. Due to the molecular weight of hyaluronic acid in the syringe ready for Viscor injection, the beneficial effects of a full course of treatment may continue for the next 48 weeks. The treatment cycle may be repeated with your doctor's advice.

A sterile injection syringe containing 50 mg of hyaluronic acid in a sterile package
Store below 30 ° C and protect from freezing.
Bring the product to room temperature before injection.